Excelsior Biopharma

Excelsior Biopharma Net Margin

The Net Profit Margin of Excelsior Biopharma (6496.TWO) as of Oct 28, 2026 is -20.39 %. In the previous year, Net Profit Margin was -11.45 % — a change of 78.06% (lower).

Net Margin

-20.39 %

YoY

78.06%

Last updated:

Net Profit Margin of Excelsior Biopharma is 2025 -20.39 % . Net Profit Margin of Excelsior Biopharma was 2024 -11.45 % . It decreases by 78.06% lower compared to the previous year.

For Excelsior Biopharma, the net margin of -20.4% is down versus -1.2% a few years ago.

The Excelsior Biopharma Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
13.13 TWD
Jan 1, 2019
4.61 TWD
Jan 1, 2020
2.45 TWD
Jan 1, 2021
-1.17 TWD
Jan 1, 2022
-5.03 TWD
Jan 1, 2023
-11.80 TWD
Jan 1, 2024
-11.45 TWD
Jan 1, 2025
-20.39 TWD
The Excelsior Biopharma Net Margin history
YEARNet MarginYoY
-20.39 %+78.06%
-11.45 %-2.91%
-11.80 %+134.73%
-5.03 %+329.78%
-1.17 %-147.82%
2.45 %-46.97%
4.61 %-64.89%
13.13 %-19.45%
16.30 %+38.68%
11.76 %+1.55%
11.58 %-13.76%
13.42 %+8,060.44%
0.16 %-21.09%
0.21 %-3.94%
0.22 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Excelsior Biopharma Stock analysis

What does Excelsior Biopharma do? Excelsior Biopharma Inc., headquartered in Taipei City, Taiwan, operates in the Health Care sector. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, including prescription and non-prescription drugs, health care products, medical equipment, and rapid test reagents. Listed on 19 December 2014, Excelsior Biopharma serves both domestic and international markets with its diverse product portfolio. Excelsior Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Excelsior Biopharma stock

Net Profit Margin of Excelsior Biopharma is -20.39 % in 2025.

Net Profit Margin of Excelsior Biopharma changed from -11.45 % to -20.39 %, representing a 78.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Excelsior Biopharma since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Excelsior Biopharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Excelsior Biopharma

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Excelsior Biopharma